Finally, due to the synergistic action of the components of MetS, individuals with MetS have pro-inflammatory and pro-thrombotic states, which can be identified by elevated serum C-reactive protein (CRP) and fibrinogen levels, contributing to cardiovascular risk (16). This evidence concerns the gene CRP and metabolic syndrome.